Sabtu, 19 Mei 2012

Genetic Test May Predict Risk Of Schizophrenia

Genetic Test May Predict Risk Of Schizophrenia

Editor's Choice
Academic Journal
Main Category: Schizophrenia
Also Included In: Genetics;  Psychology / Psychiatry
Article Date: 19 May 2012 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article
Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


Researchers at the Indiana University School of Medicine have developed a test that can predict how likely an individual is to develop schizophrenia. The scientists combined data from several different types of studies in order to identify and prioritize a group of genes most associated with the disease.

Combined, these genes can generate a score, and determine whether an individual is at lower or higher risk of developing schizophrenia. The study, which was conducted along with a group of national and international collaborators, is published online in the journal Molecular Psychiatry.

In addition, the authors applied their top genes to data from other studies of schizophrenia and were able to successfully identify which patients had been diagnosed with the disease and which had not.

When they examined the biological pathways in which the genes were active, they also proposed a model of schizophrenia, given that the disease's underlying causes are a mix of genetic variations that affect the development of the brain and neuronal connections together with environmental factors; in particular stress.

Lead researcher, Alexander B. Niculescu III, M.D., Ph.D., associate professor of psychiatry and medical neuroscience at the IU School of Medicine, and director of the Laboratory of Neurophenomics at the IU Institute of Psychiatric Research, said:

"At its core, schizophrenia is a disease of decreased cellular connectivity in the brain, precipitated by environmental stress during brain development, among those with genetic vulnerability."

Niculescu, who is also staff psychiatrist and investigator at the Richard L. Roudebush Veterans Affairs Medical Center, continued:

"For first time we have a comprehensive list of the genes that have the best evidence for involvement in schizophrenia."

Schizophrenia is a psychiatric disease that makes it difficult for the person to distinguish between real and unreal experiences and to think logically. Approximately 1% of the population is affected by the disease, often with devastating impact.

Once the new test is refined, it could help physicians and caregivers identify which young people in families with a history of the disease are more likely to develop schizophrenia, prompting early intervention and treatment.

Niculescu notes that a score indicating a higher risk of schizophrenia...:

"...doesn't determine your destiny. It just means that your neuronal connectivity is different, which could make you more creative, or more prone to illness.

It's all on a continuum; these genetic variants are present throughout the population. If you have too many of them, in the wrong combination, in an environment where you are exposed to stress, alcohol and drugs, and so on, that can lead to the development of the clinical illness."

In about two-thirds of cases, the prototype test was able to determine whether an individual was at a lower or higher risk of developing the disease.

The team found that when analyses were conducted using gene-level data, the results were stronger compared to when analyses were based on individual variations - called single nucleotide polymorphisms (SNPs) - in those genes.

Several different SNPs can trigger a particular gene's role in the development of schizophrenia. The researchers state that evidence for the genes, as well as the biological mechanisms in which they play a role, were significantly stronger from study to study than evidence for individual SNPs.

According to Dr. Niculescu, prior studies examining individual variations were difficult to replicate from study to study. However, this latest study suggests that the majority of research conducted in recent years has produced consistent results at a gene and biological pathway level.

Dr. Niculescu explained:

"There is a lot more reproducibility and concordance in the field than people realized.

Finally now, by better understanding the genetic and biological basis of the illness, we can develop better tests for it, as well as better treatments. The future of medicine is not just treatment but prevention, so we hope this work will move things in the right direction."

Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

"Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction"
M Ayalew, H Le-Niculescu, D F Levey, N Jain, B Changala, S D Patel, E Winiger, A Breier, A Shekhar, R Amdur, D Koller, J I Nurnberger, A Corvin, M Geyer, M T Tsuang, D Salomon, N J Schork, A H Fanous, M C O'Donovan and A B Niculescu
Molecular Psychiatry advance online publication 15 May 2012; doi: 10.1038/mp.2012.37 Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Genetic Test May Predict Risk Of Schizophrenia'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar